Original Research
Accepted on 24 Dec 2024
Construction of an Anaplastic Thyroid Cancer Stratification Signature to Guide Immune Therapy Selection and Validation of the Pivotal Gene HLF through In Vitro Experiments
in Cancer Immunity and Immunotherapy